Dr. Michelle Madeline Shepard, MD

Dr. Shepard practices at Roper Hospital in Charleston, South Carolina, part of Bon Secours Mercy Health.

Dr. Shepard's NPI, 1861491391, was assigned on July 18, 2005. Dr. Shepard holds South Carolina license 23565.

Dr. Shepard's primary practice is Roper Hospital, at 316 Calhoun St, Charleston, SC 29401 in Charleston County. The practice phone is (843) 724-2800.

Dr. Shepard's primary practice is Roper Hospital in Charleston, South Carolina, part of Bon Secours Mercy Health. Dr. Shepard is also affiliated with Bon Secours St. Francis Hospital. The medical group on file is 24ON Physicians of SC, LLC. Dmand AI also links Dr. Shepard to 3 more hospitals, 2 medical groups, 1 clinical lab, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shepard practices, 8 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Shepard's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Shepard's licenses on file in 2 states: South Carolina and Massachusetts.

CMS data shows 421 Medicare services from Dr. Shepard across 5 procedure codes in 2024, for 155 Medicare patients. Medicare paid $29,737 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Shepard in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 4.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shepard's median patient age at 70, with 42% women.

In 2016, Dr. Shepard wrote 41 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $885 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shepard for performance year 2024, reported through an alternative payment model (APM). Dr. Shepard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Shepard from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $18.